Auszug
Die Anovulation als monokausaler Befund in der Sterilitätsbehandlung hat nicht nur viele differenzialdiagnostisch zu erwägende Ursachen, sondern ist meist sehr suffizient auch ohne den Einsatz assistierter Reproduktionstechniken zu behandeln. Ziel ist dabei das Erreichen einer Ovulation, sei es durch direkte Stimulation oder durch Restaurierung eines eigenen spontanen ovulatorischen Zyklus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Azziz R, Black VY, Knochenhauer ES et al. (1999) Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. J Clin Endocrinol Metab 84, 946
Brettenthaler N, De Geyter C, Huber PR, Keller U (2004) Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:3835–3840.
Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM (2006) Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. Hum Reprod 21:109–20.
Cochrane Data base (2003) Insulin sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for PCOS. Cochrane Database Syst Rev (2003) 3, CD003053
Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003 79:1–13.
Coulam CB, Adamson SC, Annegers JF (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604–606
Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 (1997) 774–800
Eisenhardt S, Schwarzmann N, Henschel V, Germeyer A, von Wolff M, Hamann A, Strowitzki T. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2006 9:946–52.
Farquhar C, Vandekerckhove P, Lilford R (2003) Laparoscopic »drilling« by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome (Cochrane Review). In: The Cochrane Library, Issue 1, Oxford: Update Software
Filicori M, Flamigni C, Dellai P et al. (1994) Treatment of anovulation with pulsatile gonadotropin releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 79:1215
Garcia J, Seegar Jones GS, Wentz AC (1977) The use of clomiphene citrate. Fertil Steril 28, 707
Homburg R, Levy T, Ben-Rafael Z (1995) A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril 63: 729–33.
Klinefelter JF jr, Albright F, Griswold G (1943) Experience with a quantitative test for normal or decreased amounts of follicle stimulating hormone in the urine in endocrinological diagnosis. J Clin Endocrinol Metab 3:529–536.
Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 2694–2698
Leyendecker G, Wildt L, Plotz EJ (1981) Die hypothalamische Ovarialinsuffizienz. Gynäkologe 14:84–103.
Liguori G, Tolino A, Moccia G, Scognamiglio G, Nappi C (1996) Laparoscopic ovarian treatment in infertile patients with polycystic ovarian syndrome (PCOS): endocrine changes and clinical outcome. Gynecol Endocrinol 10, 257–264
Nugent D, Vandekerckhove P, Hughes e et al. (2000) Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome (Cochrane review)
Rebar RW (1982) Hypergonadotropic amenorrhea and premature ovarian failure: a review. J Reprod Med 27:179–186
Rossing MA, Daling JR, Weiss NS et al. (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331, 771
Rotterdam ESHRE/ ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 19–25
Schneider HPG, Hanker JP, Frantzen C (1988) Behandlung der funktionellen und organischen Unfruchtbarkeit — Sterilität/Infertilität. In: Schneider HPG, Lauritzen C, Nieschlag E (Hrsg) Grundlagen und Klinik der menschlichen Fortpflanzung. De Gruyter, Berlin, S 619–746
Strowitzki T, Vogt PH (2003) Genetik des POF-Syndroms. Gynäkologische Endokrinologie 1 128–134
Strowitzki T (2005) Praktisches Vorgehen bei gestörter Ovarfunktion und mit ihr assoziierter Phänomene. In: Leidenberger F, Strowitzki T, Ortmann O (Hrsg) Klinische Endokrinologie für Frauenärzte. Springer Verlag, p 561ff
Weise W, Honza A, Prügel P (1982) Behandlungsergebnisse bei funktioneller weiblicher Sterilität. Zentralbl Gynäkol 104, 9
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Strowitzki, T., Wildt, L. (2007). Die anovulatorische Patientin in der Reproduktionsmedizin. In: Das Deutsche IVF-Register 1996–2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-49928-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-49928-2_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-37324-7
Online ISBN: 978-3-540-49928-2
eBook Packages: Medicine (German Language)